Uniphar PLC ( (GB:UPR) ) has issued an announcement.
Uniphar PLC has announced the launch of a €35 million share buyback programme, aiming to reduce its share capital by repurchasing and cancelling shares. The programme, conducted in partnership with J&E Davy, will run until the end of 2025, subject to market conditions and regulatory compliance, and reflects Uniphar’s strategic focus on capital allocation and shareholder value enhancement.
More about Uniphar PLC
Uniphar PLC operates in the healthcare industry, focusing on providing pharmaceutical and healthcare services. The company is engaged in the distribution and supply of pharmaceutical products and related services, primarily targeting the European market.
YTD Price Performance: 17.54%
Average Trading Volume: 29,491
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £550M
For detailed information about UPR stock, go to TipRanks’ Stock Analysis page.